Thermo Fisher Scientific (TMO) Stock Forecast & Price Target

Thermo Fisher Scientific
Bull Case

Here are some ways that investors could benefit from investing in Thermo Fisher Scientific Inc.:

• Thermo Fisher Scientific Inc. recently demonstrated strong financial performance by beating analyst expectations in its most recent quarterly report, posting earnings per share of $6.03 against a consensus estimate of $5.71 and generating revenue of $11.99 billion, which exceeded the projected $11.71 billion. This beat was accompanied by a 10.5% year-over-year increase in revenue, indicating robust demand for the company's life sciences solutions and analytical instruments.
• The stock is currently trading at $614.11, which is well above its 50-day simple moving average of $580.40 and significantly higher than its 200-day simple moving average of $518.55. This technical positioning suggests strong upward momentum and investor confidence in the company's trajectory over the recent period.
• Wall Street maintains a positive outlook on the company, with a consensus rating of "Moderate Buy" and an average price target of $619.40 as of late August 2026. Recent analyst actions include UBS lifting its price target to $730 and CLSA initiating coverage with an "outperform" rating, reflecting growing institutional support for the stock.
• Thermo Fisher Scientific Inc. has raised its full-year 2026 earnings per share guidance to a range of $24.93 to $25.33, which is above the consensus estimate of $24.85. This upward revision signals management's confidence in sustaining growth and profitability throughout the remainder of the fiscal year.
• The company maintains a healthy financial position with a current ratio of 1.55 and a quick ratio of 1.18, indicating sufficient liquidity to cover short-term obligations. Additionally, the debt-to-equity ratio of 0.74 suggests a manageable level of leverage, providing a stable foundation for future investments and operations.